Pfizer to spinoff, merge off-patent drugs unit with Mylan Business News Wall Street Reporter
Pfizer Inc has agreed to spin off its off-patent branded drugs business and combine it with generic drugmaker Mylan NV , a move that leaves Pfizer with its more …